Heidi, one of our colleagues at Roche, shares her cancer journey — a powerful reminder of why patient voices matter. 🎥 Watch her story and join the conversation on making cancer care more personal and impactful. #UnitedByUnique #WorldCancerDay
Info
Roche ist ein globales Unternehmen mit Vorreiterrolle in der Erforschung und Entwicklung von Medikamenten und Diagnostika und ist darauf fokussiert, Menschen durch wissenschaftlichen Fortschritt ein besseres, längeres Leben zu ermöglichen. Dank der Kombination von Pharma und Diagnostika unter einem Dach ist Roche führend in der personalisierten Medizin - einer Strategie mit dem Ziel, jeder Patientin und jedem Patienten die bestmögliche Behandlung zukommen zu lassen. Roche ist das grösste Biotech-Unternehmen weltweit mit differenzierten Medikamenten für die Onkologie, Immunologie, Infektionskrankheiten, Augenheilkunde und Erkrankungen des Zentralnervensystems. Roche ist auch der bedeutendste Anbieter von In-vitro-Diagnostika und gewebebasierten Krebstests und ein Pionier im Diabetesmanagement. Seit der Gründung im Jahr 1896 erforscht Roche bessere Wege, um Krankheiten zu verhindern, zu erkennen und zu behandeln und leistet einen nachhaltigen Beitrag zur gesellschaftlichen Entwicklung. Zum Ziel des Unternehmens gehört es durch Kooperationen mit allen relevanten Partnern den Zugang von Patienten zu medizinischen Innovationen zu verbessern. Auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation stehen heute 30 von Roche entwickelte Medikamente, darunter lebensrettende Antibiotika, Malariamittel und Krebsmedikamente. Ausgezeichnet wurde Roche zudem bereits das neunte Jahr in Folge als das nachhaltigste Unternehmen innerhalb der Pharma-, Biotechnologie- und Life-Sciences-Branche im Dow Jones Sustainability Index. Die Roche-Gruppe mit Hauptsitz in Basel, Schweiz ist in über 100 Ländern tätig und beschäftigte 2017 weltweit rund 94 000 Mitarbeiterinnen und Mitarbeiter. Im Jahr 2017 investierte Roche CHF 10,4 Milliarden in Forschung und Entwicklung und erzielte einen Umsatz von CHF 53,3 Milliarden. Genentech in den USA gehört vollständig zur Roche-Gruppe. Roche ist Mehrheitsaktionär von Chugai Pharmaceutical, Japan. Weitere Informationen finden Sie unter www.roche.com/careers #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Website
-
http://www.roche.com/
Externer Link zu Roche
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Switzerland 🇨🇭
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data und Science
Orte
Beschäftigte von Roche
Updates
-
Every cancer journey tells a story of resilience. Together with Union for International Cancer Control (UICC) and the global cancer community, we’re working to ensure those stories shape the future — driving innovation, improving prevention, and building care that truly puts people first. #UnitedByUnique #WorldCancerDay
-
⏰ The wait is over: Applications for the 2026 Perspectives Programmes are officially open! Are you ready to turn your ambition into impact? Whether you're looking to solve complex business challenges or help deliver life-changing innovations to patients, your journey starts with a single choice. ⭐ Here’s how it works: ✅Choose your track: Business or Finance. ✅Rotate globally: Spend 2 years moving through different functions and international teams. ✅Define your path: Gain the expertise you need to become a future leader at Roche. 👇Apply now! 🔗Business Perspectives: https://lnkd.in/eTPF4Kyi 🔗Finance Perspectives: https://lnkd.in/eiStuJ95 #RochePerspectivesProgrammes #Careers #RocheCareers
-
-
Powering a healthier future: Roche has reached its 100% sustainable electricity goal worldwide. ⚡️🌱 This means our daily work for patients worldwide—from our research laboratories and manufacturing facilities to our offices and data centres— is now powered by sustainable electricity. This isn't the finish line: it’s a step on our journey toward net-zero greenhouse gas emissions across our value chain by 2045. It proves that when we work together, ambitious long-term goals turn into tangible progress. Watch the video to see what this milestone means for us. To learn more about how we got here, read the full story "Behind the Switch" on our website. 👇 🔗 https://spkl.io/6045ASlxD For further information on how Roche defines and reports climate-related claims, please refer to our Climate-Related Claims Disclosure Statement. #Roche #Sustainability #HealthierFuture
-
Explore how Roche’s Perspectives Programmes can accelerate your career and prepare you to become a leader of tomorrow. 💪 We are hosting two webcast sessions on February 12, 2026 to share the exciting opportunities available in the Business and Finance tracks. These programs provide global experiences, skill development, and the chance to make a meaningful impact through your work. 🌍✨ Don’t miss this opportunity to unlock your potential and embark on a transformative journey with Roche. 📌 Register here: Session 1: 10:00am-11:00am (CET) https://lnkd.in/dEFq_x2s Session 2: 04:00pm-05:00pm (CET) https://lnkd.in/dvKaer6g #RochePerspectivesProgrammes #Careers #RocheCareers
-
-
2025 was a strong year for Roche. We delivered strong financial results—with Group sales up 7% at constant exchange rates—but the true measure of our success lies in the impact on patients. This year, our medicines reached 62% more people worldwide than the year prior. That is the number we are most proud of. For further key highlights from our 2025 performance, watch the video below to see how we are positioning ourselves to prevent, stop, and cure diseases with the highest societal burden. And read the all the about our 2025 achievements in our Annual Report: https://spkl.io/6046Aq7nr #Roche #FinancialResults #Innovation #Healthcare
-
Roche reports strong 2025 results with 7% (CER) sales growth, driven by strong demand for medicines and diagnostic solutions. In 2025, Roche once again made significant progress: We continued on our growth path, launched important medical innovations and further strengthened our pipeline. With excellent results and a promising product pipeline, our more than 100,000 employees have helped advance our vision of a healthier future. Learn more about our 2025 results 👉 https://spkl.io/6048AqN8Q Explore more about our journey 👉 https://spkl.io/6049AqN8v
-
Advancing healthcare is all about making life simpler — for patients and professionals alike. At Roche, we’ve revolutionized mass spectrometry with groundbreaking “super beads” technology. By automating complex testing processes, we’re making diagnostics more accessible for everyday use while also leading the way toward a greener, more sustainable future. Curious to learn more about mass spectrometry? Play this short game and discover the potential of this technology! https://lnkd.in/d-vEBkpF
-
10,000 companies worldwide now have science-based climate targets validated. Roche is proud to be among these companies, with our target for net-zero greenhouse gas emissions by 2045 validated by the Science Based Targets Initiative last year. Environmental sustainability is a core part of our broader sustainability approach — because a healthier future for people and society depends on the health of our planet. Congratulations to the Science Based Targets initiative on reaching this milestone. Learn more about our climate targets: https://spkl.io/6044AUx9n #SBTi10k #ScienceBasedTargets #Sustainability #Roche
-
-
Roche strengthened its position among the world’s 100 most valuable listed companies. With a market capitalisation of USD 353 billion, we are the leading company in Switzerland and now rank 31st globally, up 15 places. A top-100 position reflects confidence in a company’s long-term ability to create value — not just today, but over many years — compared with tens of thousands of listed companies worldwide. In healthcare, lasting value is built by sustained innovation, scientific progress and meaningful impact for patients and societies. This recognition belongs to our people and partners around the world. Thank you!
-
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Roche
Insgesamt 4 Finanzierungsrunden
![]()
SoftBank
Weitere Informationen auf Crunchbase
Letzte Runde
Kapitalerhöhung nach Börsengang
Externer Crunchbase-Link für die letzte Finanzierungsrunde
5.000.000.000,00 $
Investor:innen